NASDAQ: ATHX       Athersys Inc
Last Price Today's Change   Day's Range   Trading Volume
0.722   0.00 (0.00%)  0.00 - 0.00  0


Avg Volume (4 weeks):2,861,190
4 Weeks Range:0.486 - 0.714
4 Weeks Price Volatility (%):
52 Weeks Range:0.47 - 1.81
52 Weeks Price Volatility (%):
Average Price Target: 4.00
Price Target Upside/Downside: +3.278


No recent Headlines for this stock.

Business Background

Athersys Inc is a clinical stage biotechnology company. It is focused on developing novel and proprietary therapies in the areas where there is significant unmet medical need, particularly in the regenerative medicine area. The firm's main product is Multistem cell therapy. Its current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2193  2044  355  7699 

Top 10 Active Counters
 ISBC 13.87-0.35 
 NU 3.81-0.27 
 AMD 103.37+0.90 
 NIO 16.81+0.18 
 DISCA 24.43+1.36 
 TGT 162.38-52.90 
 AMC 13.74+0.84 
 AAPL 145.98-3.26 
 SOFI 7.466+0.416 
 NVDA 180.315-1.455